CN114236023A - Porous carbon carrier, preparation method thereof and application thereof in ligand fishing - Google Patents
Porous carbon carrier, preparation method thereof and application thereof in ligand fishing Download PDFInfo
- Publication number
- CN114236023A CN114236023A CN202111446040.5A CN202111446040A CN114236023A CN 114236023 A CN114236023 A CN 114236023A CN 202111446040 A CN202111446040 A CN 202111446040A CN 114236023 A CN114236023 A CN 114236023A
- Authority
- CN
- China
- Prior art keywords
- porous carbon
- mobile phase
- hpc
- carbon carrier
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052799 carbon Inorganic materials 0.000 title claims abstract description 40
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 239000003446 ligand Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 5
- 238000010000 carbonizing Methods 0.000 claims abstract description 4
- 239000011261 inert gas Substances 0.000 claims abstract description 4
- 238000012216 screening Methods 0.000 claims description 22
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 229940052016 turmeric extract Drugs 0.000 claims description 11
- 235000020240 turmeric extract Nutrition 0.000 claims description 11
- 239000008513 turmeric extract Substances 0.000 claims description 11
- 235000014375 Curcuma Nutrition 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229920002521 macromolecule Polymers 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000003112 inhibitor Substances 0.000 claims description 5
- 238000001819 mass spectrum Methods 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 241000407170 Curcuma Species 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000011068 loading method Methods 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 239000013543 active substance Substances 0.000 abstract description 3
- 244000163122 Curcuma domestica Species 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 4
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 4
- QRMPRVXWPCLVNI-YYFQZIEXSA-N Curcumol Chemical compound C1C(=C)[C@@H]2CC[C@H](C)[C@@]22C[C@@H](C(C)C)[C@]1(O)O2 QRMPRVXWPCLVNI-YYFQZIEXSA-N 0.000 description 4
- 235000012754 curcumin Nutrition 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 4
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 3
- 235000003373 curcuma longa Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 2
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 2
- 108010058683 Immobilized Proteins Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 2
- 229940015301 baicalein Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 2
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- HUZJLWLCLJEXEL-NFAWXSAZSA-N Curcumenone Chemical compound C1C(=C(C)C)C(=O)C[C@@]2(C)[C@H](CCC(=O)C)[C@H]21 HUZJLWLCLJEXEL-NFAWXSAZSA-N 0.000 description 1
- HUZJLWLCLJEXEL-UHFFFAOYSA-N Curcumenone Natural products C1C(=C(C)C)C(=O)CC2(C)C(CCC(=O)C)C21 HUZJLWLCLJEXEL-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000533950 Leucojum Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000001237 Raman spectrum Methods 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910003481 amorphous carbon Inorganic materials 0.000 description 1
- 230000006933 amyloid-beta aggregation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012575 bio-layer interferometry Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- -1 bisdemethoxyucucumin Chemical compound 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000008540 curcumenone Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229910021385 hard carbon Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000000696 nitrogen adsorption--desorption isotherm Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention belongs to the technical field of ligand fishing, and discloses a porous carbon carrier, a preparation method thereof and application thereof in ligand fishing. The preparation method of the porous carbon carrier comprises the following steps: (1) dissolving Zn salt and polyacrylate in water to obtain a mixture; (2) and freeze-drying the mixture, and then carbonizing the mixture in inert gas to obtain the porous carbon carrier. The porous carbon carrier has good protein loading and fixing capacity, can be used for ligand fishing technology, shows good stability and repeatability, and can quickly, efficiently and accurately screen natural plant components to obtain target active substances.
Description
Technical Field
The invention belongs to the technical field of ligand fishing, and particularly relates to a porous carbon carrier, a preparation method thereof and application thereof in ligand fishing.
Background
Ligand fishing (Ligand fishing) is a Ligand and a receptor which are based on the affinity interaction between molecules to identify the interaction, and a new way is opened up for researching the interaction between biological macromolecules and ligands by combining with a modern organic analysis means. In short, ligand fishing is based on the interaction between a drug target and an active ligand, which is "fished" out of a complex sample system. The ligand fishing strategy with high sensitivity and high-throughput determination characteristics has a wide prospect in the aspect of screening active compounds, and the current research results show that the ligand fishing technology can realize the rapid screening of active products from complex extract components, and is a preferred strategy for carrying out the directional separation of natural active molecules. Since the traditional identification of biologically active compounds in natural sources involves repeated isolation and activity testing steps, these steps are time consuming, laborious and inefficient. And ligand fishing by selecting ligands from complex biological samples based on the fixation of target biomolecules on the micro-nano material can be a feasible and convenient method.
However, the micro-nano material for fixing biomolecules in the existing ligand fishing method has the defects of limited load rate, insufficient stability and the like, and the development and application of the ligand fishing method are limited to a certain extent. Based on this, the present invention is expected to provide a carrier material with better loading rate and stability, so as to better meet the requirements of ligand fishing technology in screening bioactive compounds in natural sources.
Disclosure of Invention
The present invention is directed to solving at least one of the problems of the prior art described above. Therefore, the porous carbon carrier (SAZn-HPC) has good protein loading and fixing capacity, can be used for ligand fishing technology, shows good stability and repeatability, and can be used for quickly, efficiently and accurately screening target active substances from natural plant components.
The invention provides a preparation method of a porous carbon carrier (SAZn-HPC), which comprises the following steps:
(1) dissolving Zn salt and polyacrylate in water to obtain a mixture;
(2) and freeze-drying the mixture, and then carbonizing the mixture in inert gas to obtain the porous carbon carrier.
The porous carbon carrier (SAZn-HPC) prepared by the method has good load capacity on biological macromolecules such as protein, nucleic acid and the like, so that the porous carbon carrier can be applied as a biological macromolecule fixing material and shows good stability and reproducibility.
The freeze drying employed in the present invention may provide better protection of the mixture than other drying means. Because the drying is carried out in a frozen state, the volume is almost unchanged, the original structure is kept, the condensation phenomenon cannot occur, and some substances which are easy to oxidize are protected. The freeze drying can remove more than 95-99% of water, so that the dried product can be stored for a long time without deterioration.
Preferably, the Zn salt in the step (1) is ZnCl2。
Preferably, the sodium polyacrylate in step (1).
Preferably, in step (1), the Zn salt and the polyacrylate salt are dissolved in water under ultrasonic agitation.
Preferably, in step (2), the freeze-drying is carried out when a snowflake appearance of significant volume expansion appears in the mixture.
Preferably, the inert gas in the step (2) is Ar gas.
Preferably, after the carbonization in the step (2), the operations of grinding, washing and drying are also performed.
The invention also provides a porous carbon carrier (SAZn-HPC), which is hierarchical porous carbon with monoatomic Zn sites and is prepared by the preparation method.
The invention also provides application of the porous carbon carrier in ligand fishing.
The invention also provides application of the porous carbon carrier in screening of active ingredients of natural plants. The porous carbon carrier is combined with ligand for fishing, and can be used for screening active ingredients of natural plants.
The invention also provides a ligand screening system which comprises the porous carbon carrier and biological macromolecules, wherein the biological macromolecules are fixed on the porous carbon carrier. According to the principle of affinity, the ligand screening system can be used for screening corresponding active ligands (ligand fishing) which can be specifically combined with biological macromolecules from a mixture to be screened.
Preferably, the biomacromolecule is amyloid beta (a β).
The invention also provides a method for screening the potential inhibitor of the A beta from the curcuma extract, which comprises the following steps:
s1, diluting Abeta with a buffer solution, mixing the Abeta with the porous carbon carrier, oscillating and washing to prepare Abeta @ SAZn-HPC;
s2, mixing the Abeta @ SAZn-HPC and the turmeric extract in a vortex manner, removing supernatant, incubating, washing, mixing with methanol in a vortex manner, and performing mass spectrum detection on the obtained solution;
the condition parameters of the mass spectrum detection comprise:
mobile phase composition:
mobile phase A: 0.1% (v/v) aqueous formic acid; mobile phase B: acetonitrile;
gradient elution conditions:
0-25 min: 25% -70% of mobile phase B, and the balance of mobile phase A;
25-40 min: 70-95% of mobile phase B, and the balance of mobile phase A;
40-50 min: 95-25% of mobile phase B and the balance of mobile phase A.
The turmeric is a commonly used traditional Chinese medicine in China, has the effects of promoting qi circulation, removing blood stasis, dredging channels and relieving pain, and is mainly used for treating chest and abdomen distending pain, shoulder and arm pain, intolerable heart pain, postpartum hematodynia, initial onset of sore and tinea, irregular menstruation, amenorrhea and traumatic injury. Curcuma rhizome carried by the 'Chinese pharmacopoeia' of 2020 edition is dried rhizome of Curcuma rhizome Curcuma Longa L. Modern pharmacological research shows that the turmeric has multiple biological activities of resisting inflammation, resisting cancer, protecting liver, reducing blood pressure or blood fat and the like. Among them, chemical components such as curcumin have shown a remarkable effect of preventing or treating Alzheimer Disease (AD). However, since there are many ingredients in turmeric, there is little information about the active ingredient and mechanism. The porous carbon carrier is adopted to fix amyloid beta-protein (A beta), so that the purpose of screening potential inhibitors of amyloid beta-protein (A beta) in turmeric extract can be effectively realized.
Preferably, the buffer solution in step S1 is PBS buffer solution.
Preferably, the washing is performed using PBS buffer in step S1.
Preferably, the preparation method of the turmeric extract in step S2 is: pulverizing Curcuma rhizome, adding 75% ethanol, reflux-extracting, and evaporating the filtrate under reduced pressure to remove solvent by rotary evaporator to obtain Curcuma rhizome extract.
Preferably, the condition parameters for mass spectrometry detection in step S2 further include: the collection time is about 55 min; the flow rate of the mobile phase is about 300 mu L/min; the column was Agilent ZORBAX SB-C18 (2.1X 100mm, 3.5 μm); the column temperature is 30-35 ℃; the sample size is about 10 muL; setting the voltage of an ion source to be 4.0kV, and detecting in a positive detection mode; taking nitrogen as a sheath gas and helium as an auxiliary gas, wherein the flow rates are respectively 10CFM and 0; the capillary temperature was 275 ℃; detecting in the range of m/z of 100-; the resolution is 30000; the normalized collision energy was 35% and the Q value was 0.25.
Preferably, the incubation temperature in step S2 is 35-37 deg.C, and the incubation time is 25-35 min.
Compared with the prior art, the invention has the following beneficial effects:
(1) the porous carbon carrier has good protein loading and fixing capacity, can be used for ligand fishing technology, shows good stability and repeatability, and can quickly, efficiently and accurately screen natural plant components to obtain target active substances.
(2) The method for screening the A beta potential inhibitor from the curcuma extract has the characteristics of high specificity, high screening efficiency, low labor and time cost, low requirement on sample pretreatment and the like.
Drawings
FIG. 1 is a morphological feature diagram of a porous carbon support (SAZn-HPC) in example 1 of the present invention;
FIG. 2 shows the results of the performance test of A β @ SAZn-HPC and the results of the screening for active compounds in turmeric extract in example 2 of the present invention;
FIG. 3 shows the results of biological assays performed on the active compounds screened in example 3 of the present invention.
Detailed Description
In order to make the technical solutions of the present invention more apparent to those skilled in the art, the following examples are given for illustration. It should be noted that the following examples are only preferred embodiments of the present invention, and the claimed protection scope is not limited thereto, and any modification, substitution, combination made without departing from the spirit and principle of the present invention are included in the protection scope of the present invention.
The starting materials, reagents or apparatuses used in the following examples are conventionally commercially available or can be obtained by conventionally known methods, unless otherwise specified.
Example 1
This example provides a porous carbon support, a hierarchical porous carbon with monoatomic Zn sites, named SAZn-HPC, prepared by a method comprising the steps of:
(1) reacting ZnCl2Dissolving the mixture and sodium polyacrylate in deionized water under ultrasonic stirring to obtain a mixture;
(2) freeze-drying the mixture prepared in the step (1), and then carbonizing the mixture in Ar gas to obtain a primary product;
(3) and (3) grinding, washing and drying the primary product prepared in the step (2) to prepare the porous carbon carrier SAZn-HPC.
FIG. 1 shows the morphological characteristics of the porous carbon support (SAZn-HPC), as can be seen from FIG. 1: a broad peak at 23 ℃ pointing to the (002) peak of amorphous carbon (JCPDS No.41-1487) was observed in SAZn-HPC, indicating the presence of a random combination of graphitic and turbostratic stacking (shown in FIG. 1A); from Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM), SAZn-HPC shows a typical layered porous structure, including the formation of large pores with long-range orderAnd having sidewalls (shown as B and C in fig. 1) interconnecting the mesopores/micropores; the raman spectrum of SAZn-HPC (shown as D in fig. 1) exhibits typical non-graphitic carbon characteristics with strong D-bands (due to defect induction mode) and G-bands (identified as graphitic mode); EDS mapping showed that Zn elements are highly dispersed in the network of the carbon matrix (shown as E and F in fig. 1); the nitrogen adsorption-desorption isotherms and pore size distribution curves (shown as G in FIG. 1) of SAZn-HPC show typical IV isotherms, with micropores and mesopores being observed in the material, and the Brunauer-Emmett-Teller (BET) specific surface area calculation result is about 1328.8m2(ii) in terms of/g. Based on the larger mass and stronger scattering power of the Zn element, a dark field probe of AC-TEM was used, and this result confirmed the atomic dispersion of the Zn element (shown in H and I in fig. 1).
In summary, the prepared SAZn-HPC has a layered porous structure with typical hard carbon characteristics, abundant structural defects, high BET surface area and enlarged interlayer spacing (0.395nm), and Zn and C elements show uniform distribution characteristics.
Example 2
This example provides a ligand screening system comprising amyloid beta protein (A β) and the porous carbon support SAZn-HPC prepared in example 1, named A β @ SAZn-HPC. The preparation method of the ligand screening system comprises the following steps:
(1) dissolving A beta in hexafluoroisopropanol, performing ultrasonic treatment for 15min, drying in a nitrogen blowing instrument to obtain an A beta film, and storing in a refrigerator at-80 ℃ for later use. The resulting a β films were re-dissolved with DMSO and PBS, and a β was incubated at 37 ℃ for 5 days to form an aggregated form of a β for assay.
(2) A β was diluted with PBS to various concentrations (0.125mg/mL, 0.250mg/mL, 0.500mg/mL), mixed with SAZn-HPC prepared in example 1, washed three times with 4.0mL PBS overnight in a shaker at 4 ℃ and centrifuged at 1000 Xg for 10 minutes to prepare A β @ SAZn-HPC.
Comparative example 1
The SAZn-HPC prepared in example 1 was vortexed in 0.5mM HCl to remove Zn single atoms, and the resulting sample was designated as HPC. The same preparation method as in example 2 was used to prepare the corresponding ligand screening system a β @ HPC, using the HPC obtained as the material.
Load performance, stability and reproducibility testing
The content of A β @ SAZn-HPC in example 2 and the content of A β @ HPC supported by A β @ HPC in comparative example 1 were measured using the BCA kit, and the results are shown in A of FIG. 2. In the presence of a certain amount of a β, the loading capacity of SAZn-HPC and HPC increases with increasing a β concentration until the final loading capacity is reached. However, at the same A β concentration, the maximum adsorption capacity of SAZn-HPC for A β is significantly higher than that of HPC. The results indicate that SAZn-HPC has better loading capacity and higher adsorption capacity than HPC.
And B in FIG. 2 is the stability results of A β @ SAZn-HPC and A β @ HPC, the amount of SAZn-HPC immobilized protein decreased rapidly in the first two days, slowly in the third to sixth days, and the amount of HPC immobilized protein decreased continuously in six days after storage at 4 ℃. This result indicates that a β can be more effectively immobilized on SAZn-HPC by the interaction between atomically dispersed Zn sites and amino acid residues of a β.
In addition, the reproducibility between batches was evaluated by fixing the content of a β protein, and the test results are shown in table 1. The results show that both SAZn-HPC and HPC have good reproducibility with RSD values less than 2.0%.
TABLE 1 reproducibility test results
RSD(%) | Intra-day(n=3) | Inter-day(n=3) |
SAZn-HPC | 1.87 | 1.89 |
HPC | 1.7 | 1.47 |
Example 3
This example provides a method for screening for potential inhibitors of a β from turmeric extract comprising the steps of:
(1) pulverizing Curcuma rhizome, extracting with 75% (v/v) ethanol under reflux for 2 hr, evaporating the filtrate under reduced pressure in rotary evaporator, and storing at 4 deg.C;
(2) vortex mixing the a β @ SAZn-HPC prepared in example 2 with the turmeric extract of step (1), removing the supernatant, incubating at 37 ℃ for 30min, washing 3 times with PBS, vortex mixing with 70% methanol, and subjecting the resulting solution to mass spectrometric detection analysis; control experiments were also performed using PBS instead of turmeric extract.
The condition parameters of mass spectrum detection comprise:
mobile phase composition:
mobile phase A: 0.1% (v/v) aqueous formic acid; mobile phase B: acetonitrile;
gradient elution conditions:
0-25 min: 25% -70% of mobile phase B, and the balance of mobile phase A;
25-40 min: 70-95% of mobile phase B, and the balance of mobile phase A;
40-50 min: 95-25% of mobile phase B and the balance of mobile phase A.
The collection time was 55min, and the column chromatography was Agilent ZORBAX SB-C18 (2.1X 100mm, 3.5 μm); the flow rate of the mobile phase is 300 muL/min, the column temperature is 35 ℃, and the sample injection amount is 10 muL. The ion source voltage was set to 4.0kV and detection was performed in the positive detection mode. Nitrogen as the sheath gas and helium as the auxiliary gas, at flow rates of 10CFM and 0, respectively. The capillary temperature was 275 ℃, measured in the range of m/z of 100-.
The turmeric extract was analyzed by the above method, 64 compounds were determined according to the exact mass number and fragment number, as shown in fig. 2C to I, and 5 compounds having strong affinity to Α β @ SAZn-HPC, including curcumenol (56), curcumenol (33), demethoxycurcumin (38), bisdemethoxycurcumin (36) and curcumin (42), were selected according to the peak area, and curcumenol (37), which is a less affinity compound, was selected as a negative control.
Biological verification: a.beta.was diluted with PBS and incubated at 37 ℃ for 7 days. The sample solution was diluted in a solution of thioflavin-T (ThT) to a final concentration of 20. mu.M. 190. mu.L of ThT solution and 10. mu. L A. beta. were mixed into a 96-well plate and incubated for 1 h. Fluorescence measurements were performed using a microtiter plate reader at 450 and 490nm excitation. ThT can be used to further monitor and confirm inhibition of a β fibril formation in vitro. Fluorescence intensity indicated that the concentration of a β fibrils increased after treatment with dimethyl sulfoxide (DMSO) and curcumol, indicating no effect in resisting a β fibril formation (shown in fig. 3 a). The fluorescence intensity is proportional to the formation of a β fibrils. The stronger the fluorescence, the more a β fibrils are formed. The experimental result shows that the anti-A beta fibril formation function is curcumin > bisdemethoxycurcumin > baicalein > demethoxycurcumin > curcumenone > curcumenodiene > curcumenol alcohol in sequence.
EZ-Link NHS-LC-LC-biotin was dissolved in DMSO to a concentration of 10 mM. A β was biotinylated with biotin reagents in a molar ratio of 1:0.5 and incubated at room temperature for 30min before being added to a 96-well plate and the biotinylation was determined by loading the mixture onto a Super Streptavidin (SSA) volumetric pipette and detecting by Forte BIO Octet Red instrument. The screened compounds were dissolved in DMSO, diluted with PBS to the appropriate concentration to a final volume of 200. mu.L/well and an equivalent amount of D MSO was added to the control wells. Consists of a repeating cycle of four main steps: wash (300s), baseline (120s), bind (120s) and dissociate (120 s). Results including association and dissociation patterns and kinetic constants were analyzed using Forte. BIO data analysis software. The results showed that the KD values of curcumin, bisdemethoxyucucumin, baicalein, demethoxyucumin, furadodine, curcumenol and curcumol were 2.52, 4.44, 13.1, 17.5, 32.9, 44.6 and 232 μ M, which respectively showed direct and reversible interactions with a β (shown in fig. 3 as B to H).
According to the invention, SAZn-HPC is adopted to screen out active ingredients for inhibiting A beta aggregation in the curcuma extract, and Tht and biolayer interferometry are adopted to verify, so that the accuracy of the established ligand fishing system is ensured.
The embodiments of the present application have been described in detail with reference to the drawings, but the present application is not limited to the embodiments, and various changes can be made within the knowledge of those skilled in the art without departing from the gist of the present application. Furthermore, the embodiments and features of the embodiments of the present application may be combined with each other without conflict.
Claims (10)
1. A method for preparing a porous carbon support, comprising the steps of:
(1) dissolving Zn salt and polyacrylate in water to obtain a mixture;
(2) and freeze-drying the mixture, and then carbonizing the mixture in inert gas to obtain the porous carbon carrier.
2. The method according to claim 1, wherein the Zn salt and the polyacrylate salt are dissolved in water under ultrasonic agitation in step (1).
3. A porous carbon support, characterized by being hierarchical porous carbon having monoatomic Zn sites, which is produced by the production method according to any one of claims 1 to 2.
4. Use of the porous carbon support of claim 3 in ligand fishing.
5. Use of a porous carbon support according to claim 3 in the screening of natural plant active ingredients.
6. A ligand screening system comprising a biological macromolecule and the porous carbon support of claim 3, said biological macromolecule being immobilized on said porous carbon support.
7. The ligand screening system of claim 6, wherein the biomacromolecule is a β.
8. A method for screening potential inhibitors of A beta from turmeric extract, comprising the steps of:
s1, diluting A beta with a buffer solution, mixing the A beta with the porous carbon carrier of claim 3, and oscillating and washing to prepare A beta @ SAZn-HPC;
s2, mixing the Abeta @ SAZn-HPC and the turmeric extract in a vortex manner, removing supernatant, incubating, washing, mixing with methanol in a vortex manner, and performing mass spectrum detection on the obtained solution;
the condition parameters of the mass spectrum detection comprise:
mobile phase composition:
mobile phase A: 0.1% aqueous formic acid; mobile phase B: acetonitrile;
gradient elution conditions:
0-25 min: 25% -70% of mobile phase B, and the balance of mobile phase A;
25-40 min: 70-95% of mobile phase B, and the balance of mobile phase A;
40-50 min: 95-25% of mobile phase B and the balance of mobile phase A.
9. The method of claim 8, wherein the turmeric extract of step S2 is prepared by: pulverizing Curcuma rhizome, adding 75% ethanol, reflux-extracting, and evaporating the filtrate under reduced pressure to remove solvent by rotary evaporator to obtain Curcuma rhizome extract.
10. The method according to claim 8, wherein the incubation in step S2 is performed at a temperature of 35-37 ℃ for a period of 25-35 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111446040.5A CN114236023B (en) | 2021-11-29 | 2021-11-29 | Porous carbon carrier, preparation method thereof and application thereof in ligand fishing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111446040.5A CN114236023B (en) | 2021-11-29 | 2021-11-29 | Porous carbon carrier, preparation method thereof and application thereof in ligand fishing |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114236023A true CN114236023A (en) | 2022-03-25 |
CN114236023B CN114236023B (en) | 2024-06-25 |
Family
ID=80752291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111446040.5A Active CN114236023B (en) | 2021-11-29 | 2021-11-29 | Porous carbon carrier, preparation method thereof and application thereof in ligand fishing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114236023B (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009236734A (en) * | 2008-03-27 | 2009-10-15 | Kinjo Gakuin | Method for separating and refining curcumins from turmeric powder (curcuma powder) by high speed counter flow chromatography |
CN201845009U (en) * | 2010-11-11 | 2011-05-25 | 郝书顺 | Integrated quantitative sampling reagent adding device |
CN202204706U (en) * | 2011-08-12 | 2012-04-25 | 石家庄禾柏生物技术股份有限公司 | Integral sample collecting injection device |
CN107192749A (en) * | 2017-04-14 | 2017-09-22 | 上海师范大学 | Detect the electrochemical luminescence immunosensor and its structure of amyloid beta |
CN109433214A (en) * | 2018-11-17 | 2019-03-08 | 扬州工业职业技术学院 | A kind of porous catalysts supported on carbon of Ni/Zn and its application in phenyl ring catalytic hydrogenation |
CN109507174A (en) * | 2019-01-16 | 2019-03-22 | 济南大学 | Preparation based on the compound ZnO nanoparticle quenching Particles in Electrochemiluminescofce ofce Luminol sensor of curcumin |
JP2020081165A (en) * | 2018-11-20 | 2020-06-04 | 株式会社クレハ | AMYLOID β REMOVAL TOOL, ORGANISM DERIVED LIQUID PURIFICATION SYSTEM, AMYLOID β REMOVAL METHOD AND AMYLOID β REMOVAL ADSORBENT |
CN111359061A (en) * | 2020-03-13 | 2020-07-03 | 北京控制工程研究所 | Miniature whirl nozzle structure of lung delivery device |
CN112351790A (en) * | 2018-06-29 | 2021-02-09 | 好侍健康食品株式会社 | Composition for treating, preventing or ameliorating alzheimer's disease, composition for inhibiting brain nerve cell death, composition for inhibiting beta amyloid-induced microglial activation, and composition for inhibiting beta amyloid-induced PGE2, TNF- α or IL-1 β production |
CN113149003A (en) * | 2020-11-12 | 2021-07-23 | 同济大学 | In-situ ultra-small zinc nanocrystalline template method for synthesizing nitrogen-doped porous carbon, method and application |
CN113697808A (en) * | 2021-08-26 | 2021-11-26 | 山东交通学院 | Transition metal oxide-loaded porous carbon material, and preparation method and application thereof |
CN114226709A (en) * | 2021-11-15 | 2022-03-25 | 澳门科技大学 | Nano porous bismuth and preparation method and application thereof |
CN115671311A (en) * | 2022-10-18 | 2023-02-03 | 广州金研生物医药研究院有限公司 | Carbon-copper metal organic framework nano composite material and preparation method and application thereof |
-
2021
- 2021-11-29 CN CN202111446040.5A patent/CN114236023B/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009236734A (en) * | 2008-03-27 | 2009-10-15 | Kinjo Gakuin | Method for separating and refining curcumins from turmeric powder (curcuma powder) by high speed counter flow chromatography |
CN201845009U (en) * | 2010-11-11 | 2011-05-25 | 郝书顺 | Integrated quantitative sampling reagent adding device |
CN202204706U (en) * | 2011-08-12 | 2012-04-25 | 石家庄禾柏生物技术股份有限公司 | Integral sample collecting injection device |
CN107192749A (en) * | 2017-04-14 | 2017-09-22 | 上海师范大学 | Detect the electrochemical luminescence immunosensor and its structure of amyloid beta |
CN112351790A (en) * | 2018-06-29 | 2021-02-09 | 好侍健康食品株式会社 | Composition for treating, preventing or ameliorating alzheimer's disease, composition for inhibiting brain nerve cell death, composition for inhibiting beta amyloid-induced microglial activation, and composition for inhibiting beta amyloid-induced PGE2, TNF- α or IL-1 β production |
CN109433214A (en) * | 2018-11-17 | 2019-03-08 | 扬州工业职业技术学院 | A kind of porous catalysts supported on carbon of Ni/Zn and its application in phenyl ring catalytic hydrogenation |
JP2020081165A (en) * | 2018-11-20 | 2020-06-04 | 株式会社クレハ | AMYLOID β REMOVAL TOOL, ORGANISM DERIVED LIQUID PURIFICATION SYSTEM, AMYLOID β REMOVAL METHOD AND AMYLOID β REMOVAL ADSORBENT |
CN109507174A (en) * | 2019-01-16 | 2019-03-22 | 济南大学 | Preparation based on the compound ZnO nanoparticle quenching Particles in Electrochemiluminescofce ofce Luminol sensor of curcumin |
CN111359061A (en) * | 2020-03-13 | 2020-07-03 | 北京控制工程研究所 | Miniature whirl nozzle structure of lung delivery device |
CN113149003A (en) * | 2020-11-12 | 2021-07-23 | 同济大学 | In-situ ultra-small zinc nanocrystalline template method for synthesizing nitrogen-doped porous carbon, method and application |
CN113697808A (en) * | 2021-08-26 | 2021-11-26 | 山东交通学院 | Transition metal oxide-loaded porous carbon material, and preparation method and application thereof |
CN114226709A (en) * | 2021-11-15 | 2022-03-25 | 澳门科技大学 | Nano porous bismuth and preparation method and application thereof |
CN115671311A (en) * | 2022-10-18 | 2023-02-03 | 广州金研生物医药研究院有限公司 | Carbon-copper metal organic framework nano composite material and preparation method and application thereof |
Non-Patent Citations (10)
Also Published As
Publication number | Publication date |
---|---|
CN114236023B (en) | 2024-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chaurand et al. | Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections | |
Bodzon‐Kulakowska et al. | Imaging mass spectrometry: instrumentation, applications, and combination with other visualization techniques | |
Judd et al. | A recommended and verified procedure for in situ tryptic digestion of formalin‐fixed paraffin‐embedded tissues for analysis by matrix‐assisted laser desorption/ionization imaging mass spectrometry | |
Schwartz et al. | Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression | |
Pan et al. | Using oxidized carbon nanotubes as matrix for analysis of small molecules by MALDI-TOF MS | |
Chaurand | Imaging mass spectrometry of thin tissue sections: a decade of collective efforts | |
Balluff et al. | MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications | |
Zhao et al. | Solid-state NMR of unlabeled plant cell walls: high-resolution structural analysis without isotopic enrichment | |
Laird et al. | Distinguishing black carbon from biogenic humic substances in soil clay fractions | |
Horatz et al. | Conjugated polymers as a new class of dual-mode matrices for MALDI mass spectrometry and imaging | |
Moussa et al. | Effects of drying process on an IgG1 monoclonal antibody using solid-state hydrogen deuterium exchange with mass spectrometric analysis (ssHDX-MS) | |
Zhu et al. | Electrospun highly ordered mesoporous silica–carbon composite nanofibers for rapid extraction and prefractionation of endogenous peptides | |
Wang et al. | Cryo-EM and single particles | |
Wang et al. | Development of N, S-doped carbon dots as a novel matrix for the analysis of small molecules by negative ion MALDI-TOF MS | |
Krishna et al. | Crystallization of proliferating cell nuclear antigen (PCNA) from Saccharomyces cerevisiae | |
Han et al. | MIL-101 (Cr) as matrix for sensitive detection of quercetin by matrix-assisted laser desorption/ionization mass spectrometry | |
Ma et al. | Copper (II) ions-immobilized virus-like hollow covalent organic frameworks for highly efficient capture and sensitive analysis of amyloid beta-peptide 1–42 by MALDI-MS | |
Li et al. | Co-incorporated mesoporous carbon material-assisted laser desorption/ionization ion source as an online interface of in vivo microdialysis coupled with mass spectrometry | |
CN110174459A (en) | Application of the golden cluster in Matrix-assisted laser desorption ionization detection | |
Terracciano et al. | Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization | |
Tian et al. | Reduce the matrix effect in biological tissue imaging using dynamic reactive ionization and gas cluster ion beams | |
CN114236023A (en) | Porous carbon carrier, preparation method thereof and application thereof in ligand fishing | |
Patil et al. | MALDI sample preparation methods: A mini review | |
Zhu et al. | An auxiliary matrix for routine analysis of small molecules and biological macromolecules using matrix-assisted laser desorption ionization mass spectrometry | |
Hussain et al. | Facile liquid-phase deposition synthesis of titania-coated magnetic sporopollenin for the selective capture of phosphopeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |